Maider Medical Industry Equipment Co. Ltd. (SHA:688310)
China · Delayed Price · Currency is CNY 14.20
+0.10 (0.71%)
Sep 14, 2026, 3:00 PM CST
SHA:688310 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 466.34 | 447.42 | 274.85 | 480.22 | 383.49 | 315.53 |
Revenue Growth | 86.20% | 62.79% | -42.77% | 25.22% | 21.54% | 19.89% |
Gross Profit Gross Profit Growth | 199.88 | 197.86 | 117.92 | 244.5 | 192.06 | 156.21 |
Operating Income Operating Income Growth | 10.23 | 46.94 | -29.48 | 105.74 | 66.41 | 57.01 |
Net Income Net Income Growth | 42.53 | 64.94 | -19.98 | 99.83 | 67.02 | 64.48 |
Earnings Per Share EPS Growth | 0.25 | 0.40 | -0.12 | 0.61 | 0.41 | 0.39 |
EPS Growth | - | - | - | 49.84% | 3.61% | 8.48% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Medical Consumables Intelligent Equipment Stand-Alone - Safe Infusion Medical Consumables Intelligent Equipment Stand-Alone - Safe Infusion Growth | 144.07 | 154.53 | 63.9 | 65.64 |
Medical Consumables Intelligent Equipment Stand-Alone - Blood Purification Medical Consumables Intelligent Equipment Stand-Alone - Blood Purification Growth | 121.62 | 104.17 | 13.45 | 2.81 |
Medical Consumables Intelligent Equipment Stand-Alone -Drug-Device Combination Medical Consumables Intelligent Equipment Stand-Alone -Drug-Device Combination Growth | 139.97 | 1.77 | - | - |
Others Others Growth | 39.94 | 12.58 | 70.2 | 43.84 |
Total Total Growth | 445.6 | 273.06 | 480.22 | 383.49 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 253.88 | 385.97 | 268.28 | 344.93 | 290.1 | 354.87 |
Total Debt Total Debt Growth | 64.33 | 62.82 | 30.36 | 1.77 | 1.37 | 2.72 |
Net Cash (Debt) Net Cash Growth | 189.55 | 323.15 | 237.92 | 343.16 | 288.73 | 352.15 |
Net Cash Growth | -35.68% | 35.82% | -30.67% | 18.85% | -18.01% | -17.23% |
Net Cash Per Share Net Cash Per Share Growth | 1.12 | 1.99 | 1.43 | 2.10 | 1.75 | 2.15 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 20.38 | 151.22 | 56.56 | 110.91 | 97.34 | 84.89 |
Capital Expenditures CapEx Growth | -55.46 | -53.95 | -86.02 | -72.21 | -135.7 | -112.65 |
Free Cash Flow Free Cash Flow Growth | -35.08 | 97.26 | -29.46 | 38.7 | -38.36 | -27.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 42.86% | 44.22% | 42.90% | 50.91% | 50.08% | 49.51% |
Operating Margin | 2.20% | 10.49% | -10.73% | 22.02% | 17.32% | 18.07% |
Pretax Margin | 5.41% | 13.62% | -10.64% | 26.54% | 22.74% | 22.34% |
Profit Margin | 9.12% | 14.52% | -7.27% | 20.79% | 17.48% | 20.43% |
FCF Margin | -7.52% | 21.74% | -10.72% | 8.06% | -10.00% | -8.80% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.250 | 0.250 | - | 0.357 | 0.245 | 0.194 |
Dividend Per Share Growth | 0% | - | - | 45.81% | 26.30% | -23.99% |
Dividend Yield | 1.67% | 1.65% | - | 1.74% | 2.01% | 0.88% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 56.29 | 38.63 | - | 35.36 | 31.36 | 59.75 |
Forward PE | - | 9.97 | 9.97 | 22.52 | 14.65 | 36.14 |
P/FCF Ratio | - | 25.79 | - | 91.20 | - | - |
PS Ratio | 4.92 | 5.61 | 6.51 | 7.35 | 5.48 | 12.21 |